WisdomTree BioRevolution FundWDNA
Type
ETF
Peer group
Global equity
Net assets
$2.3M
Expense ratio
0.45%
1-year return
+69.7%
3 years, a year
+14.0%
5 years, a year
-1.9%
12-month yield
3.22%
Holdings
86
What it aims to do.
The WisdomTree BioRevolution Fund (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (the Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| MRNA Moderna Inc | 4.54% |
| JNJ Johnson & Johnson | 3.15% |
| UTHR United Therapeutics Corporation | 2.80% |
| PFE Pfizer Inc. | 2.74% |
| LLY Eli Lilly & Co. | 2.64% |
| STOK Stoke Therapeutics Inc | 2.53% |
| NTRA Natera Inc | 2.53% |
| AMGN Amgen Inc. | 2.35% |
| TWST Twist Bioscience Corporation | 2.31% |
| JOBY AstraZeneca PLC | 2.28% |
More on WDNA.
- WDNA overview
- WDNA holdings
- WDNA risk
- WDNA costs
- WDNA money in and out
- WDNA share classes
- Compare WDNA with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.